Loading...
Loading...
Among the 7 tracked institutional investors we monitor, LXEO (LEXEO THERAPEUTICS INC) is held with a combined value of $129.61M across 19,736,739 shares. The largest holder is VANGUARD GROUP INC with a position worth $38.67M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 5 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$129.61M
Total Shares Held
19,736,739
Institutional Holders
7
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $38.67M | 0.00% | New |
| 2 | BlackRock, Inc. | $29.34M | 0.00% | +4.1% |
| 3 | CITADEL ADVISORS LLC | $22.07M | 0.00% | +1.9% |
| 4 | STATE STREET CORP | $20.48M | 0.00% | +11.9% |
| 5 | Point72 Asset Management, L.P. | $9.65M | 0.01% | -11.3% |
| 6 | MILLENNIUM MANAGEMENT LLC | $9.26M | 0.00% | +77.6% |
| 7 | FMR LLC | $139.99K | 0.00% | +82.2% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of LXEO with a position worth $38.67M, representing 0.00% of their portfolio. In total, 7 institutional investors hold LXEO with a combined value of $129.61M.
In the most recent quarter, 1 fund opened a new position in LXEO. Additionally, 5 increased their holdings and 1 reduced their positions.
Institutional investors hold $129.61M worth of LXEO stock across 7 positions. The largest institutional holder is VANGUARD GROUP INC with $38.67M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For LXEO, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their LXEO positions.